[Brexpiprazole for treatment of schizophrenia: a critical literature study].

Conclusion Brexpiprazole is a treatment option for schizophrenia, with a relatively favorable side effect profile. The position of brexpiprazole within the current treatment algorithm should become clear through future research and clinical experience. Tijdschrift voor Psychiatrie 63(2021)1, 48-55. PMID: 33537974 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33537974?dopt=Abstract

Source: Tijdschrift voor Psychiatrie - February 6, 2021 Category: Psychiatry Authors: Spoelstra SK, Baas CAJ, Knegtering H Tags: Tijdschr Psychiatr Source Type: research